logo

Amgen Inc. (AMGN)



Trade AMGN now with
  Date
  Headline
6/19/2017 9:04:51 AM FDA Accepts Amgen's SBLA To Expand Indication For XGEVA To Include Multiple Myeloma Patients
6/7/2017 9:03:21 AM Amgen And Allergan Says FDA Panel Will Review Data Supporting BLA For ABP 215 On July 13
6/5/2017 9:03:51 AM Amgen Submits SBLA To FDA And A Variation To Marketing Authorization To EMA For Repatha (evolocumab)
6/4/2017 10:56:13 AM Amgen Presents New Data From Phase 3 XGEVA Study In Patients With Multiple Myeloma
5/18/2017 9:01:56 AM Amgen Submits Biologics License Application To FDA For Erenumab